These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 3716289)

  • 1. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic transfusion reaction due to interdonor kell incompatibility. Report of two cases and review of the literature.
    Reiner AP; Sayers MH
    Arch Pathol Lab Med; 1990 Aug; 114(8):862-4. PubMed ID: 2198004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibody anti-Kell (K1). An analysis of two post-transfusion haemolytic reactions (author's transl)].
    Fischer O; Snopková O
    Cas Lek Cesk; 1981 Jan; 120(3-4):96-9. PubMed ID: 7214435
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoanti-K antibody mimicking an alloantibody.
    Viggiano E; Clary NL; Ballas SK
    Transfusion; 1982; 22(4):329-32. PubMed ID: 7101426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic transfusion reaction due to interdonor incompatibility].
    Skov F; Dybkjaer E; Taaning E; Thygesen V; Drachmann O
    Ugeskr Laeger; 1985 Dec; 147(51):4205-6. PubMed ID: 4090069
    [No Abstract]   [Full Text] [Related]  

  • 7. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdonor incompatibility as a cause of reaction during granulocyte transfusion.
    Morse EE
    Vox Sang; 1978; 35(4):215-8. PubMed ID: 695439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-K1 of the IgA class associated with Morganella morganii infection.
    Pereira A; Monteagudo J; Rovira M; Mazzara R; Reverter JC; Castillo R
    Transfusion; 1989; 29(6):549-51. PubMed ID: 2749877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A delayed transfusion reaction caused by anti-K6.
    Taddie SJ; Barrasso C; Ness PM
    Transfusion; 1982; 22(1):68-9. PubMed ID: 7064210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic transfusion reaction due to anti-Kell undetectable in low-ionic-strength solutions.
    Molthan L; Strohm PL
    Am J Clin Pathol; 1981 Apr; 75(4):629-31. PubMed ID: 7223723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Irregular agglutinins and the compatibility test: the elements of choice].
    Rouger P; Salmon C
    Rev Fr Transfus Immunohematol; 1983 Feb; 26(1):5-13. PubMed ID: 6407087
    [No Abstract]   [Full Text] [Related]  

  • 14. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
    Pujani M; Pahuja S; Dhingra B; Chandra J; Jain M
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reaction caused by anti-Jsb in a Js(a+b+) patient.
    Waheed A; Kennedy MS
    Transfusion; 1982; 22(2):161-2. PubMed ID: 6978557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic transfusion reaction due to inter-donor kell incompatibility: report of two cases and review of the literature.
    Shulman IA
    Arch Pathol Lab Med; 1991 Jan; 115(1):7. PubMed ID: 1987918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.